Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
May 24, 2000

Wyeth Ayerst Laboratories Recalls Meperidine HCL Injection

St. Davids, PA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Wyeth Ayerst Laboratories is conducting a recall of Meperidine HCL Injection, USP, because of lack of assurance of sterility.

The Meperidine HCL Injection is a prescription for relief of moderate to severe pain, for pre-operative medication, for support on anesthesia, and for obstetrical analgesia. 

The recall affects:

50 mg/mL in 30mL vial, NDC #0008-0258-01 with the Lot numbers 4970174 EXP 11/00, 4980176 EXP 6/01, 4980216 EXP 7/01 or 4990104 EXP 2/02.

100 mg/mL in 20 mL vial, NDC #0008-0259-0, with the Lot numbers 4970175 EXP 11/00, 4980213 EXP 6/01, 4980214 EXP 9/01, 4990084 EXP 3/02.

FDA stated in its report that approximately 95,786 vials were distributed nationwide.

This ongoing Class II recall was initiated by the company, by letter dated March 13, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-356/357-0

Notice of this product warning was sent via email to SafeMail subscribers May 24, 2000.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.